CellCentric

Biotechnology · Cambridge, United Kingdom · Founded 2003 · Privately Held (backing)

Operator of a clinical-stage cancer therapy biotechnology company intended to focus on novel drug development for specific cancers. CellCentric is based in Cambridge, United Kingdom and was founded in 2003. It is valued at about $382 million as of Oct 2026, set by institutional fund marks. It has raised $281 million across 2 recorded rounds; the latest was an $116 million Series C in Apr 2025.

PMV mark · valuation
$382.5M
Oct 2026
Priced at
its later-stage round
Apr 2025
Total raised
$280.5M
Last round
Later Stage VC (Series C)
Apr 2025
How much has CellCentric raised?
$280.5Macross 2 recorded rounds · Jul 2024 – Apr 2025

Most recently, CellCentric raised $116.5M in its Later Stage VC (Series C) (Apr 2025).

Free account
More of CellCentric with a free account
  • ·The complete investor list: 20 names
  • ·Watch CellCentric: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CellCentric round by round

2 rounds
Apr 2025Later Stage VC (Series C)$116.5M▮
+ 1 more investors · free account
Jul 2024Later Stage VC (Series B)$35.5M▮
+ 1 more investors · free account

How much has CellCentric raised?

CellCentric has raised $281 million in total; 2 of its rounds are on record. The largest on record was a $35.5 million Series B in Jul 2024; the most recent was an $116 million Series C in Apr 2025.

CellCentric investors

20 investors are on record for CellCentric, including Innovate UK, RA Capital Management, 5Y Capital and Future Planet Capital. By type, the record holds 8 venture capital firms and 1 asset manager. The Series C in Apr 2025 drew 3 investors.

For fundraisers
Raising for a company like CellCentric?

20 investors have backed CellCentric — start your target list with the firms already writing checks in biotechnology.

See all 20 investors →

Frequently asked about CellCentric

How much has CellCentric raised?
CellCentric has raised $280.5M in total across 2 recorded funding rounds.
When was CellCentric's last funding round?
CellCentric's most recent recorded round was Later Stage VC (Series C) in Apr 2025, raising $116.5M.